US2016194662A1PendingUtilityA1

Recombinant virus-like particles encoded by multi-gene vector

Assignee: PFIZERPriority: May 1, 2009Filed: Feb 26, 2016Published: Jul 7, 2016
Est. expiryMay 1, 2029(~2.8 yrs left)· nominal 20-yr term from priority
A61P 31/12A61P 43/00A61P 31/16A61P 37/04A61P 31/20C12N 2760/16123C12N 7/00C12N 2710/20034C12N 2710/14143C12N 2710/20023A61K 2039/5256C12N 2710/16123A61K 2039/5258C12N 2760/16134C12N 2710/14043C12N 15/866C12N 2760/16023C12N 15/86C12N 7/04
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention describes novel virus-like particles for use as vaccines, diagnostic tools and R&D tools based on recombinant DNA and cell cultivation techniques for production. The recombinant virus-like particles of the invention are assembled by polypeptide chains that incorporate several, in particular two or more, different epitopes which are selected either (a) from different viral strains of the same virus and/or (b) from different serotypes of the same virus and/or (c) from different viral strains specific for different hosts. These epitopes are then displayed on the particle surface.

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled) 
     
     
         17 . A single baculoviral vector encoding a recombinant virus-like particle comprising
 (i) two or more polynucleotides coding for different epitopes or different proteins comprising epitopes which are selected either (a) from different viral strains of the same virus and/or (b) from different serotypes of the same virus and/or (c) from different viral strains specific for different hosts;   (ii) polynucleotides coding for proteins forming a complete virus-like surface; and   (iii) polynucleotides coding for capsid and/or nucleopore proteins.   
     
     
         18 . The baculoviral vector according to  claim 17  comprising three or more different epitopes or different proteins comprising epitopes. 
     
     
         19 . The baculoviral vector according to  claim 17  comprising four or more different epitopes or different proteins comprising epitopes. 
     
     
         20 . The baculoviral vector according to  claim 17  comprising six, nine or twelve epitopes or different proteins comprising epitopes. 
     
     
         21 . The baculoviral vector according to  claim 17  wherein the epitopes are from three or more different virus strains or serotypes. 
     
     
         22 . The baculoviral vector according to  claim 17  further comprising B- and/or T-cell epitopes. 
     
     
         23 . The baculoviral vector according to  claim 17  further comprising fluorescent proteins, proteins useful for purification purposes of the particles or for attaching a label, and/or proteinaceous structures required for transport processes. 
     
     
         24 . The baculoviral vector according to  claim 17  wherein the virus is influenza virus. 
     
     
         25 . The baculoviral vector according to  claim 17  wherein the virus is human papilloma virus. 
     
     
         26 . A single baculoviral vector comprising a polynucleotide selected from SEQ ID NO:1-5. 
     
     
         27 . A host cell comprising a vector according to  claim 17 . 
     
     
         28 . A host cell comprising a vector according to  claim 18 . 
     
     
         29 . A host cell comprising a vector according to  claim 19 . 
     
     
         30 . A host cell comprising a vector according to  claim 20 . 
     
     
         31 . A host cell comprising a vector according to  claim 21 . 
     
     
         32 . A host cell comprising a vector according to  claim 22 . 
     
     
         33 . A host cell comprising a vector according to  claim 23 . 
     
     
         34 . A host cell comprising a vector according to  claim 24 . 
     
     
         35 . A host cell comprising a vector according to  claim 25 . 
     
     
         36 . A host cell comprising a vector according to  claim 26 .

Join the waitlist — get patent alerts

Track US2016194662A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.